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ABSTRACT 
An alpha-one protein is separated from human serum on a  microbead column. This non- 
dialyzable protein induces the immediate growth of unadapted cells placcd in chemically 
defined Medium A2 -t- APG. HeLa, conjunctiva and human heart cclls, which stop growing 
if the protein is removed, continue to grow only if the protein is returned or the cells are 
permitted to adapt to the defincd medium. A  90-120 day pcrlod is required for adaptation. 
The spreading and growth of fully adapted cells is also  stimulated by the addition of the 
protein. As little as 0.4 ~g per ml of medium is effective.  The protein analyzed by paper, 
starch, and discontinuous acrylamidc gel electrophorcsis appears to be a single component. 
Thc protein is pcriodate-Schiff positive and readily binds small  molecules  which are re- 
moved, without loss of biological activity, by precipitating the protein in 50%  saturated 
ammonium sulfate. The protein is adsorbed on the microbead column as a complex with the 
beta lipoprotein fraction of human serum; it cannot be separated from bovine or equine- 
scra by this method; and it is not identical with fctuin. Its biological response is not dupli- 
cated by insulin, carbamyl phosphate, putrescine, or linolcic acid. 
INTRODUCTION 
An alpha-one type  protein isolated from human 
serum has been shown to be equally effective  in 
stimulating both  the  growth  and  spreading  of 
cultured  human  cells.  This  protein  is  nondi- 
alyzable. The biological activity of thc alpha-one 
protein  was  tested  on  monolayer cultures using 
three  different  human  cell  lines,  HeLa  (Gey), 
conjunctiva (Chang), and human heart (Girardi). 
Two findings with respect to its biological activity 
were  noteworthy.  First,  the  alpha-one  protein 
could replace serum in those stock cultures which 
wcrc  maintained  on  the  defined  base  medium 
plus serum. Second, those  strains which had been 
adapted  to  the  chemically defined base medium 
without serum and which have been demonstrated 
to grow indefinitely in this defined medium were 
stimulated  to  enhanced  growth  and  spreading 
when treated with preparations of the alpha-one 
protein. 
Electrophoretic  patterns  have  shown  that  the 
material  is  not  fetuin  obtained  from  fetal  calf 
serum by Fisher, Puck, and Sato (7),  or the light 
and  heavy  sedimenting  fractions  described  by 
Marr,  Owen,  and  Wilson  (20).  Though  bio- 
logically much more active than either of Michl's 
calf serum  preparations  (21,  22)  by a  factor  of 
250 and 80, respectively, it is not known whether 
this increase in activity is due to greater purity of 
the protein or the use of a more effective,  defined 
base  medium  (14).  In  biological  activity  this 
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material  described by  Lieberman  and  Ove  (18) 
who  used  a  base medium of  greater  complexity 
than  that  used  by  Michl;  their  report  lacks  the 
necessary data  for  comparison  of electrophoretic 
properties.  Since  the  human-derived  alpha-one 
protein is  intimately associated with  the lipopro- 
telns in the initial stages of purification, as will be 
described later,  it  was considered useful  to  show 
by electrophoretic and biological means that  the 
protein  differed from  any  lipoproteins, of a  1.20 
density  or  less,  prepared  by  ultracentrifugation. 
Finally,  a  biological  comparison  has  been  made 
which  showed  that  its  effect on  the  growth  and 
spreading of human,  cultured  cells could  not be 
duplicated by  those small  molecular weight sub- 
stances (23)  which have been suggested as replace- 
ments for fetuin. 
MATERIALS  AND  METHODS 
Preparation of Serum 
Bovine and equine sera were obtained from Grand 
Island  Biological  Co.,  Grand  Island,  N.  Y.  Fresh 
human serum was prepared from whole blood which 
was  allowed to clot in sterile, silicone-coated tubes. 
After standing overnight at 4°C the clear supernatant 
serum was withdrawn by pipette. 
Human serum was  also prepared from outdated, 
nonhemolyzed,  ACD-preserved blood.  The  plasma 
was decanted from the red cells and then centrifuged 
for 15  rain at 2,000  rpm to remove particulate mat- 
ter.  1 volume of the plasma was then dialyzed over- 
night  against  10  volumes of 0.6%  sodium chloride. 
Clot formation in the dialyzed plasma was induced by 
adding calcium chloride to a concentration of 0.1%. 
The  resulting  serum,  hereafter  called  processed 
serum, was squeezed from the clot through a cheese 
cloth bag.  At this point,  if necessary, the processed 
serum  could  be  frozen and  stored  at  --70°C  until 
needed. 
Preparation of Biologically Active 
Alpha-One  Protein 
The  ground-glass  column  procedure  of  Carlson 
(2)  was  modified  in  the  following respects.  Soda- 
lime glass microbeads, Class IV,  (Microbeads Div., 
Cataphote Corp., Jackson, Miss.) were substituted for 
crushed glass, sodium was substituted for potassium 
in the first two during electrolyte solutions, and the 
sequence of developing solutions was changed from 
that recommended by Carlson (2)  to that described 
below. 
5 kg of beads was boiled in aqua regia, rimmed  with 
distilled water, and then washed with 1 liter of 0.6 M 
sodium bicarbonate solution adjusted to pH 8.0 with 
sodium hydroxide. A  5.8  X  40 cm column was filled 
to a depth of 24 cm with the washed beads and fur- 
ther conditioned with 200  ml more of the  same  bi- 
carbonate solution just before adding the serum. 
Either fresh or processed serum was adjusted to pH 
8.0 with 0.1 N sodium hydroxide, and 20 ml, to which 
was  added  1 mg of phenol red,  was placed  on  the 
column. The elution sequence was as follows : (a)  200 
ml  of 0.6M  sodium  bicarbonate  solution,  pH  8.0; 
(b)  100 ml of a mixture of 0.6 M sodium bicarbonate 
and 0.2 M sodium carbonate, at pH 9.5;  (c)  100 ml of 
water; (d)  100 ml of a  mixture  of 0.6  M potassium 
bicarbonate  and  0.2 M potassium carbonate with  a 
permissible range of pH 9.6-9.8; (e)  100 ml of water; 
and  (f)  200  trd  of 0.2 M potassium carbonate.  The 
column effluent was collected in 20 ml fractions. The 
column was operated at both room temperature and 
35°C, at a flow rate not exceeding 125 ml per hr. 
The  presence of protein in  each  of the  fractions 
was  determined either  by  spotting  the  fraction  on 
paper  and staining the dried spots with 0.5%  solu- 
tion of bromopheuol blue in ethanol saturated with 
HgCls (15)  or by the method of Daughaday, Lowry, 
Rosebrough, and Fields (4).  Lipids were determined 
by the method of Sperry and Brand (29), using 10 ml 
of sample concentrated to  1 ml.  Carbohydrates were 
determined  by  the  method  of  Svennerholm  (31). 
Fractions 23-27 contained the active substance (Fig. 
1).  These  fractions  were  combined  and  dialyzed 
against water. The dialyzed solution of active material 
was  adjusted  to  pH  8.0  with 0.01 N potassium hy- 
droxide  and  sterilized  by  cold  filtration  through 
Morton glass filters  (Corning Glass Works, Corning, 
N.  Y.).  (The  filters,  prior  to  use,  were  cleaned  in 
hot concentrated sulfuric acid plus  5%  (v/v)  nitric 
acid, then washed by aspiration with distilled water, 
0.1%  sodium  bicarbonate  solution,  and  distilled 
water).  A  portion of the solution was dried to con- 
stant weight at  105°C  for the determination of the 
solids content. 
The above solution which was biologically as effec- 
tive,  volume for volume,  as  the original serum was 
further purified. For this purpose the dialyzed solu- 
tion  was  adjusted  to  pH  7.2  in  a  carbon  dioxide 
atmosphere, using  phenol red  as  an  indicator,  and 
frozen. Immediately upon thawing, the cloudy solu- 
tion was centrifuged and the biologically active pre- 
cipitate dissolved in a small volume of water adjusted 
to pH  10 with dilute potassium hydroxide. The dis- 
solved precipitate was  centrifuged; the  supernatant 
was dialyzed against water and concentrated by slow 
evaporization  at  4°C.  Fractions  eluted  at  pH  8.9 
and 35°C contained sufficient lipid material that the 
active  protein  removed  by  50%  saturated  am- 
monium floated, like a lipoprotein, to  the top of the 
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dures,  the retention of maximum  biological  activity 
guided each detail and each step. 
Preparation of Lipoproteins 
Fresh or processed serum was used to prepare the 
lipoproteins  according  to  Lindegren,  Nichols,  and 
Freeman  (19).  The different fractions were recentri- 
fuged to ensure that residual nonlipoprotein proteins 
were  removed.  This  was  accomplished by  layering 
3  rnl  portions of each fraction under  9.5  ml  of KBr 
solution,  1.21  density, and recentrifuging the layered 
tubes  for  22  hr  at  38,000  rpm.  The  final  fractions 
were dialyzed to remove salts and  adjusted either to 
pH  7.2  for determination of biological effects, or to 
pH 8.0 for chromatography. 
slide is shown in Fig.  2.  The large  area of the slide 
was  covered  with  18  ml  of  7.5%  acrylamide  gel 
monomer mix,  (see Table I)  and the glass cover im- 
mediately  installed,  avoiding  air  bubbles.  The  box 
containing the slide was flushed with nitrogen. After 
20 rain the divider was removed  and the remaining 
small area of the slide covered with 4 ml of 5% acryl- 
amide  gel  monomer  mix  (Table  I).  Three  sample 
slot molds were installed (Fig.  1), leaving a clearance 
of 1 mm between the bottom of each slot and the gel- 
glass interface. The mold for the slots was located 0.5 
cm  from  the  edge  of the  glass  covering  the  7.5% 
running gel. The box containing the slide was again 
flushed  with  nitrogen,  and  polymerization  of both 
gels was allowed to progress to completion overnight. 
The following morning  the sample slot mold was 
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FIGURE  1  Separation  of  serum  on 
glass mierobeads at  ~5°C, showing the 
percentage  of  total  protein  and  lipid 
material  found  in  each  fraction.  All 
fractions  were  tested  for  biological 
activity  (see  text).  Activity  was  lo- 
cated  in  fractions  ~8-~7  inclusive. 
Electrophoretic Analysis and Separations 
(a)  Starch  gel  electrophoresis and  staining  of the 
patterns with  amido black  10B  dye was carried  out 
according to Smithies  (28). 
(b)  Discontinuous  thin  layer  acrylamide  gel elec- 
trophoresis, an original method capable of separating 
human  sera  into  28  different  protein  components, 
based on the works of Raymond  (27), Davis  (5)  and 
Ornstein  (24), was carried out as follows  A  31/~ X  4 
inches glass slide was ground on one side with 600 gr 
carborundum powder (The Carborundum Company, 
Niagara Falls, N. Y.). The ground slide was cleaned 
in  a  70°C bath ot sulfuric acid containing 5% nitric 
acid,  rinsed,  and dried.  The slide was ringed  (1  cm 
wide)  with  a  thin layer  ot  5%  acrylamide  gel  (see 
Table I) which was allowed todry for 6 hr. The ring 
acted  at  a  later  stage  to  cement  the  edges  of the 
matrix gel to the glass. 
A  plastic divider was placed 2 cm from the end of 
the slide and two thin strips of plastic, 1/~ inch thick, 
were laid along each side to act as spacers for a glass 
cover.  Both  ends  oi  the  slide  were  rimmed  with 
Vaseline  and  the slide  placed  in  a  level  box  which 
could be filled with nitrogen. The arrangement of the 
removed and the slide was ready for use. A  ~  dilu- 
tion  of whole  serum  was  used  for  serum  patterns. 
Albumin  crystalline  human  albumin  (Pentex  Inc., 
Kankakee,  Ill.),  and  fetuins,  according  to  Fisher, 
Puck,  and  Sato  (7)  (Colorado  Serum  Co.,  Denver, 
Colo.)  as well as according to Deutsch  (6)  and Spiro 
(30)  (Grand  Island  Biologicals),  were  prepared  in 
1% solutions. After filling each sample slot with pro- 
tein solution,  K150  dye mixture  (Kensington Scien- 
tific Supply Co., Berkeley, Calif.) was spotted on top 
of the gel between each sample slot.  Electrical con- 
tact to the plate was established using  double layers 
of 3MM  Whatman filter paper  (H.  Reeve Angel  & 
Co., Clifton, N. J.). Both electrode vessels were filled 
with  0.1675  M boric  acid  adjusted  to  pH  8.6  with 
sodium hydroxide. The slide was  developed  (2/l~  to 
3  hr)  using  100  v  DC  until  the  blue  marker  in  the 
K150  dye  mixture  had  reached  the  far  edge of the 
glass cover. 
The glass cover was carefully removed from the top 
of the gel and the slide stained for 30 min in  amido 
black  10B  dye solution  (28).  The  slide was  washed 
clear of excess dye with several changes of 20%  eth- 
anol  solution  containing  2%  of acetic  acid.  A  few 
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Composition  of Acrylamide  Gel Solutions 
Aronsson's  Buffer  (1) :  2-hydroxymethyl 
2-amino  1-3  propanediol,  10.8  g;  disodium 
ethylenediaminetetra~icetic,  1.3;  Boric  acid, 
0.8; Water  to  1 liter,  pH 8.9 
5% acryla-  7.5%  acryla-  5% acryla- 
mide gel for  mide gel  mide gel stack- 
ringing plate  running gel  ing sampling 
ml  ml  ml 
Solution*  1  2.5  7.5  2.5 
Solution 2  2.5  5.0  -- 
Solution 3  --  --  2.5 
Water  8.0  13.5  8.0 
Deaerate  before adding deaerated  Soln. 4 
Solution 4  2.5  5.0  2.5 
*  Solution  1 
Solution 2 
Solution 3 
Solution 4 
15  g  acrylamide  plus  0.4  g  bis- 
acrylamide in 50 ml water. 
1.0 ml tetramethyl ethylene diamine 
in  100 ml Aronsson's buffer. 
0.5 ml tetramethyl ethylene diamine 
plus  8.4  ml  Aronsson's buffer  ad- 
justed  to  pH 6.0  with acetic  acid, 
final volume 50  ml. 
0.4  ammonium  persulfate  in  50  ml 
of water. 
drops of glycerin were added to the final wash solu- 
tion, after which the slide was air dried. 
(¢)  Paper  electrophoresis has been described  (15). 
(d) Two  nonionic  surfactants,  Igepal  CO  730, 
and  alkyl  phenoxy polyoxethylene ethanol (General 
Aniline and Film Corporation, Dyestuff &  Chemical 
Division, New York)  and Renex 648,  a  polyethylene 
alkyl  aryl  ether  (Atlas  Chemical  Industries  Inc., 
Wilmington,  Del.),  which  have  been  shown to  pre- 
vent  the  trailing  of lipoproteins  (17),  were  used  in 
conjunction with certain of the paper  and starch gel 
electrophoretic  experiments.  Concentration  of  the 
surfactant  added to the borate buffer was varied be- 
tween 0.1  and  1.0a/v. 
(e)  Electrophoretic patterns were stained for perio- 
date-Schiff-reactive  material  using  the  method  of 
Green et al.  (10). 
Medium A2 -4- APG for Cell Cultures 
Chemically  defined  Medium  A2  (salts,  carbohy- 
drates, amino acids, cofactors, and vitamins) has been 
described in detail (14). In the present study,  1 nag of 
acetyleholine  chloride,  10  mg  of sodium  pyruvate, 
and  10  mg  of D-galactosamine  hydrochloride  were 
added to each 100 rrd of Medium A2. This was desig- 
nated  Medium A2  -4- APG. 
This  medium  may  be  prepared  ahead  of time  if 
frozen  and  stored  at  --70°C,  otherwise  it  must  be 
o ~~ 
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FIaURE  ~  Design  of  discontinuous  aerylamide  gel 
plate:  (a)  ring,  1 em wide, of  5%  aerylamide gel;  (b) 
ground  glass  projection  slide  31/~ X  4  inches;  (e) 
plastie form, removable;  (d)  plastic  divider;  (e)  glass 
cover  plate,  covering  7.5%  running  gel;  (f)  plastic 
spacers  1/~  inch  thick;  (g)  mold  for  sample  slots  set 
in 5% spacer gel. 
used immediately or be oxidized rapidly.  A  satisfac- 
tory state of reduction exists when  10 ml of medium 
placed  in  an  evacuated  Thunberg  tube  (Corning 
Glass  Works,  Corning,  N.  Y.)  reduce  0.5  ml  of  a 
0.01 cfv methylene blue solution at  37°C  in less than 
45 min. 
Maintenance of Stock Cultures 
Unadapted  stocks of HeLa,  conjunctiva,  and  hu- 
man heart cells were carried as monolayer cultures in 
either glass or polystyrene flasks, with Medium A2  q- 
APG supplemented with  10%  dialyzed  serum.  The 
serum  supplement  consisted  of human  serum,  from 
which the lipoproteins had  been  removed  by  ultra- 
centrifugation  at  1.20  density  (3,  16)  followed  by 
dialysis against saline. 
From the stock cultures, three strains were adapted 
to  grow  continuously  as  monolayer  cultures  in  Me- 
dium  A2  -{-  APG  without  any  serum  supplement. 
The HeLa cell which was the first strain to be adapted 
has been grown for 6 yr (14). Conjunctiva and human 
heart strains were adapted later in the same manner 
as the HeLa strain,  and have been under culture for 
2 yr. Growth of  cultures was measured by determining 
the change in total cell protein, by using the method 
of Oyama and Eagle  (25). 
EXPERIMENTAL 
Separation  and  Properties  of 
Alpha-One  Protein 
Thc  method  for  separating  biologically  active 
alpha-one protein on glass microbeads is described 
under Materials and Methods. The distribution of 
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alpha-one protein, third from the top. The 5% gel has a sufficiently  large pore size to permit running  of the 
alpha-protein, but the pores  are too large to give detailed separations of  Spiro's and Deutsch's type 
fetuins, first and second patterns from the top. Nor is the gel adequate for separation of human serum, hot- 
tom pattern. 
total  protein  and  lipid  material  between  the 
various fractions is shown in Fig.  1.  The distribu- 
tion  of carbohydrate  material,  since  it  appeared 
to  be  identical  with  that  of  the  protein,  is  not 
shown  in  Fig.  1.  In  Fig.  1  many of the  protein 
peaks  slightly precede  the  lipid  peaks  suggesting 
that  some  of  the  serum  proteins,  probably  the 
lipoproteins,  were  adsorbed  on  the  microbeads 
with lipid material interposed between the surface 
of the beads and the protein. 
Fig.  3  shows  a  5%  acrylamide  gel  electro- 
phoretic  pattern  in  which  the  active  material, 
prepared by freezing (see Materials and Methods), 
is  compared  with  that  of  pooled  human  serum 
and  two  inactive fetuin  preparations.  The  active 
material  which  appears  as  a  broad  band  in  the 
alpha-one  position  also  exhibited  considerable 
trailing.  Patterns  obtained  on  both  starch  gel 
(28)  and  paper  were  very  similar.  With  5% 
acrylamide the density of the gel is not sufficient 
to  bring about the degree of separation than can 
be  obtained by using a  7.5%  acrylamide gel.  A 
7.5% gel pattern is shown in Fig. 4. In this pattern 
the  bulk  of  the  active  fraction  remains  at  the 
point  at  which  the  protein  enters  the  7.5%  gel. 
The remainder of the pattern is free of any of the 
proteins  seen  in  the  serum  patterns  directly 
below,  and  free  from  any of the  proteins  in  the 
fetuin  patterns  seen  directly  above.  Since  the 
active  material  does  not  readily  enter  the  7.5% 
gel and enters the 5 %  gel with considerable trail- 
ing,  it  would  appear  to  be  a  relatively  large 
molecule, possibly micellar in behavior. 
Extraction of fractions 23-27 with either acetone 
or  diethyl  ether  prior  to  electrophoresis  did  not 
reduce  trailing.  Addition  of nonionic surfactants 
(see Materials and Methods)  to either the sample 
or the developing electrolyte did not reduce trail- 
ing.  It was  of interest to  note that  none of these 
procedures  impaired  biological  activity  of  the 
protein.  Cholic  acid did reduce  the  trailing and, 
as  previously reported  in abstract  form  (17),  the 
electrophoretic  mobility,  on  paper,  of  the  main 
alpha-one band was increased so that it appeared 
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alpha-one protein, third from the top. The bulk of the alpha protein under these conditions remains at the 
5% stacking gel-7.5% running gel interface. Traces  of protein which run into the 7.5% gel have a re- 
duced lipid content. Spiro's and Deutsch's fetuins are represented by the first and second patterns  from 
the top. Serum is represented by the bottom sample. 
in  the  position  usually  occupied  by  prealbumin. 
On  eluting  the  alpha-one  protein  plus  the  small 
amount  of  cholic  acid  associated  with  it,  and 
electrophorizing  on  paper,  in  a  cholic  acid-free 
system,  trailing  was  again  observed.  Throughout 
this  procedure,  biological activity was  also unim- 
paired. 
As  a  result  of further  attempts  to  improve  the 
electrolytic  appearance  of the  alpha-one  protein, 
new  properties  of  the  material  were  discovered. 
When  the  material  isolated  from  the  column 
fractions  23-27  was  rechromatographed  on  the 
glass bead column, contrary  to its initial behavior 
it no  longer exhibited  retardation  but  was  found 
at  the  solvent front.  This suggested  the possibility 
that  the  retardation  observed  on  the first passage 
was due to association with some other component 
of serum.  Accordingly,  a  preparative  run  on  the 
glass beadcolumn  was stopped  after  development 
with  the  pH  9.5  sodium  bicarbonate-carbonate 
solution and,  instead  of the usual water wash,  the 
column  was  stripped  with  0.2  M KeCO3  solution 
which  removed  all  remaining  protein  and  lipid 
material.  The material in the KeCOa effluent was 
precipitated  from  solution  by  saturation  with 
CO2,  and  the precipitate was collected by centrif- 
ugation.  The  supernatant  was discarded  and  the 
solid pellet which dissolved in K2CO8 solution was 
dialyzed  against  water.  Electrophoretic  patterns 
on  a  portion  of  the  dialyzed  material  on  5% 
acrylamide  gel  were  stained  for  protein  with 
bromophenol  blue reagent and  with  Sudan  black 
B.  The major protein band  appeared  in the  posi- 
tion  of the  alpha-one  protein,  and  Sudan  black 
B  staining  material  was  found  in  the  position  of 
beta  lipoprotein.  The  remainder  of the  dialyzed 
material,  containing  both  alpha-one  and  beta 
lipoprotein,  was  then  subjected  to  the  standard 
preparative  procedure  on  the  glass bead  column. 
As is in  the  initial  run,  active alpha-one  protein, 
free  of  beta  lipoprotein,  was  found  in  fractions 
23-27.  From  these  experiments  it was  concluded 
that  retardation  of the  alpha-one  protein  on  the 
glass  bead  column  was  due  to  association  with 
beta lipoprotein and  that  attachment  to the glass 
bead  surface  took  place  in  the  presence  of  the 
beta lipoprotein. 
The  lipoproteins  which  were  prepared  from 
human  serum  by  density  gradient  centrifugation 
were  themselves biologically inactive and  did  not 
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the glass bead column. 
Upon subjecting the alpha-one protein to paper 
chromatography,  using a  mixture of 45  vol  bu- 
tanol, 10 vol acetic acid and 45 vol water, several 
ninhydrin reactive spots  were observed.  On pre- 
cipitating the protein with 50% saturated ammo- 
nium sulfate,  these  ninhydrin-reactive substances 
were removed without loss of biological activity. 
Comparison of Fetuin with Alpha-One Protein 
Fetuin from  embryonic sera,  prepared  by  the 
method  of Fisher,  Puck,  and  Sato,  has  been re- 
ported to exhibit biological properties resembling 
those  of the  alpha-one protein.  Therefore  fetuin 
and alpha-one protein were compared. 
Starch  and  acrylamide  gel  electrophoretic 
patterns of fetuin (Colorado Serum Co.,  Denver, 
Colorado)  were made. The discontinuous acryla- 
mide gel patterns shown in Fig. 5 are to be com- 
pared with those  of the alpha-one protein shown 
in  Figs.  3  and  4.  Compared  to  the  alpha-one 
protein pattern with its  single broad  band  (Fig. 
3),  the  fetuin  patterns  shown  in  Fig.  5  had  at 
least  four  major bands and  a  number of minor 
bands, the latter varying between batches.  Trail- 
ing,  characteristic  of the  human alpha-one pro- 
tein, appeared to be absent in the fetuin patterns. 
The  fetuin  pattern  shown  in  Fig.  5  exhibited 
characteristics  identical with  those  described  by 
Marr,  Owen,  and  Wilson  (20).  Both  the  active 
human and fetuin fractions were stained with the 
periodate-Schiff reagents, 
Some  growth  substances,  besides  being  pre- 
pared from human sera,  have also been prepared 
from bovine and equine sera  (18,  14). Attempts, 
by means of a  microbead column, were not suc- 
cessful in separating from either of these  sera  an 
alpha-one  type  protein,  containing  properties 
similar to those  of the human alpha-one protein. 
In  both  cases  biological activity was  located  in 
the  fraction removed by  sodium bicarbonate at 
pH  8.0.  This  fraction  included the  bulk  of the 
serum  proteins.  However,  although  no  active 
material was present in the potassium bicarbonate 
pH 9.6-9,8 fraction, one explanation of this result 
could be that no beta lipoprotein, which is essen- 
tial for alpha-one protein adsorption, eluted from 
the  column  after  the  pH  9.6-9.8  fraction  was 
removed. 
FmVRE 5  A comparative detailed discontinuous 7.SVflv acrylamide gel pattern of Fisher et al. (6) fetuin, 
second from the top. Note that this pattern shows at least four major components as well as a number of 
minor components. The top and bottom patterns illustrate the type of separation achieved using two dif- 
ferent specimens of human serum. The third pattern from the top is that of crystalline bovine albumin 
obtained from Pentex; this material is homogeneous by immunoelectrophoresis (18). 
RICHARD Hor~S  A Growth-Promoting  Alpha-One Protein  303 FmURE 6  Effect of ~  #g/ml  of purified alpha protein on replicate 
cultures of cells adapted to grow in chemically defined medium,  a, c 
and  e represent ~4-hr-old cultures of HeLa,  conjunctiva and  human 
heart cells, respectively, b, d  and f  represent replicate ~4-hr-old  cul- 
tures of the same cells with alpha protein added to the medium. 
304  TRE  JOURNAL OF  CELL  BIOLOGY •  VOLUME  ~,  1967 FIGURE 7  Effect of alpha-one protein on replicate cultures of unadapted human heart cells placed in 
chemically defined medium: a,  ~¢-hr-old culture,  no alpha-one  protein  added;  b,  ~4-hr-old  culture,  8 
/zg/ml of alpha-one protein added to the medium. 
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FIGURE 8  Growth  of adapted  and  unadapted 
conjunctiva  cells.  Triplicate  experiments  were 
conducted  with  replicate  cultures.  Growth  is 
reported  as  the  average  increase  in  total  cell 
protein.  The  top  set  of four  curves  represents 
the  growth  of  adapted  cells  in:  medium  con- 
taining  ~0%  processed  serum,  lipoproteins  re- 
moved;  medium  containing  ~0%  processed 
serum lipoproteins,  not removed; medium con- 
taining 8  #g/ml of alpha protein; and  medium 
chemically  defined  with  nothing  added.  The 
bottom set  of two curves represents  growth  of 
unadapted  cells  in  medium  containing  8/zg of 
alpha protein and in  medium chemically defined 
with nothing added. 
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Alpha-One Protein 
The response to the alpha-one protein of strains 
of HeLa  (Gey), conjunctiva  (Chang),  and human 
heart  (Girardi)  cells,  which  had  been  previously 
adapted  to and  were growing in defined medium, 
is  shown  in  Fig.  6.  The  control  cultures  without 
added  alpha-one  protein  are  shown  in  Fig.  6  a, 
c,  and  e;  HeLa  cells,  conjunctiva  and  human 
heart,  respectively.  Cultures  of these cells  supple- 
mented  with  2/~g of alpha-one  protein  per  ml  of 
medium  are  shown,  respectively,  in  Fig.  6  b,  d 
and f.  The  spreading  and  growth  of the  cell due 
to  the  alpha-one  protein  are  apparent.  Further 
tests  showed  that,  in  the  case  of the  conjunctiva 
cells,  as little as  0.4  #g  of alpha-one  protein  per 
ml of medium initiated a  like response.  The other 
two  cell  lines  required  slightly  more,  between 
0.8  and  1.0  t~g of alpha-one  protein. 
The  effect of alpha-one  protein  on  unadapted 
cells,  when  first  transferred  to  the  medium,  was 
also  determined.  With  8  #g  per  ml  of medium, 
growth  commenced  within  24  hr  after  the  cells 
were  transferred  from  the  stock  medium  contain- 
ing  serum  to  the  defined  medium  containing  no 
serum.  Fig.  7  a  shows  a  culture  of  unadapted 
human heart cells 24 hr after removal of the serum. 
Fig.  7  b  shows a  culture  to  which alpha-one  pro- 
tein  was  added  in  place  of serum.  The  survival 
and  growth  of cells in  the medium  supplemented 
with  alpha-one  protein  were  high  compared  to 
those of the contrcl.  At the end  of 10 consecutive 
subcultures,  alpha-one  protein  was removed from 
the  medium.  Growth  promptly  stopped  and  was 
not  resumed  unless  the  alpha-one  protein  was 
returned  to the medium.  If the alpha-one  protein 
was not returned,  the cells continued  through  the 
customary 90-120 day period of adaptation  to the 
defined medium. 
FIaunE  9  Replicate monolayer cultures of unadapted conjunctiva cells.  Cultures incubated for ~4  hr: 
a, Chemically defined Medium A~ ~  APG; b, 0.01 mg insulin per ml; c, 3  X  10  -l° M linoleic acid per ml ; 
d, ~ b~g alpha-one protein per ml; e, 1 X  10  -9  M putrescine per ml; f, 1  X  10  -9 M plus 3 X  10  -1° M  linoleic 
acid per ml; g, 100 #g carbamyl phosphate  per ml; h,  100/zg carbamyl phosphate plus 0.01 mg insulin 
per ml. 
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junctiva cells  under  the  above  conditions.  The 
top  set  of  curves  were  obtained  with  fully 
"adapted"  cells.  The  highest  rate  was  obtained 
in  medium  supplemented  with  20%  processed 
human serum (see Materials and Methods)  from 
which  the  lipoproteins  had  been  removed  by 
ultracentrifugafion. Progressively  decreasing rates 
were obtained with processed human serum which 
still contained the lipoproteins, the alpha-protein 
supplemented  medium,  and  the  chemically  de- 
fined medium without any supplement. 
The  bottom  set  of  growth  curves,  shown  in 
Fig.  8,  were  obtained  with  "unadapted"  cells. 
Whereas these cells grew very slowly in the defined 
medium,  the  growth  rate  of a  replicate set was 
stimulated by the alpha protein. 
A  number of substances of known composition 
which  had  been  reported  stimulatory  to  cell 
cultures  were  tested  to  determine whether  they 
could induce an effect similar to that of the alpha- 
one  protein.  Insulin (8,  23),  linoleic acid  (11), 
putrescine  (l 1),  and  carbamyl  phosphate  (23) 
were  tested.  None of these  materials induced the 
immediate growth of unadapted conjunctiva cells 
(Fig.  9).  It was noted that insulin improved the 
appearance of the cells. These materials were not 
examined for their effect on the period of adapta- 
tion. 
DISCUSSION 
The  biologically active  protein,  which  has  been 
subject of the above experiments, has been desig- 
nated as an alpha-one protein, a name assigned in 
conformity  with  the  customary  designation  of 
proteins appearing in electrophoretic  patterns as 
bands in the area of albumin. The marked trail- 
ing of this material on electrophoretic migrations 
appears to be characteristic.  At least to date,  all 
efforts  to  eliminate  a  trailing  component  have 
failed. This, coupled with the reduction of trailing 
in the presence of cholic acid and followed  by the 
reappearance  of  trailing  on  elimination of  the 
cholic acid,  suggests  that  trailing is indeed char- 
acteristic and that present preparations are prob- 
ably homogeneous. 
The association of this alpha-one protein with 
beta lipoprotein in the glass bead column and in 
the solution, infranatant to the fractions of density 
up to  1.22 obtained by density gradient centrifu- 
gation,  suggest  that  interaction  between  these 
two high molecular weight species is characteristic 
in  the  native  state.  When deprived  of the  beta 
lipoprotein, the  alpha-one protein was  shown  to 
hold  small  molecular  weight  ninhydrin-positive 
substances  very  tenaciously.  These  observations 
suggest  that the binding power of this protein for 
certain substances is considerable. In view of these 
demonstrable adsorptive properties of the  alpha- 
one protein, it is reasonable to consider that it has 
its  effect  on  the  growth  and  spreading  of cells 
through  attachment  to  the  external  cell  wall 
surface  (12,  9).  However,  even  granting  this 
possibility,  the  mechanism by which it exerts  its 
e,Tect is unknown. 
The  method  for  preparation  of the  alpha-one 
protein from human serum cannot be successfully 
applied  to  the  preparation  of  fetuin.  Indeed, 
electrophoretic analyses show  that  the  alpha-one 
protein and  fetuin are  di rerent.  The  only simi- 
larity  observed  between  alpha-one  protein  and 
fetuin  was  in  carbohydrate  moieties and  in  the 
biological  response  of  cells.  One  commercially 
available  fetuin  gave  a  low  biological  response 
relative to that of the alpha-one protein, and two 
others were quite inactive. If fetuin preparations 
of  Fisher,  Puck  and  Sato,  (7)  contained  trace 
amounts  of  alpha-one  protein,  it  could  not  be 
detected  by electrophoretic  analysis.  From  these 
results  it  may  be  concluded  that  the  alpha-one 
protein derived from human serum is not identical 
with fetuin. It is also unlikely that the activity of 
fetuin is due to contamination with the alpha-one 
protein. The inability to prepare active alpha-one 
protein from adult bovine, or equine serum  does 
not  prove  the  absence  of  an  alpha-one  protein 
from embryonic calf serum at  a  particular stage 
of development. 
That  the  alpha-one  protein  is  not  separated 
from either adult bovine or  equine sera  may be 
because  these  sera  lack  lipid-bearing  material 
with adsorptive properties comparable to those of 
the human beta lipoprotein fraction.  It has been 
shown elsewhere  (15)  that in the bovine species a 
large  alpha  type  lipoprotein,  absent  at  birth, 
appears during the first  7 days after birth.  Thus 
when  bovine  or  equine  sera  are  processed  for 
biologically active  material,  which  may not  be 
the same as the human alpha-one protein, it is not 
adsorbed  but  discharged  from  the  microbead 
column  in  the  first  few  fractions,  along  with 
other serum proteins including this large lipopro- 
tein fraction. 
Lieberman  and  Ove  (18)  by  using  a  DEAE 
cellulose column found that they could prepare a 
growth-stimulating  substance  from  bovine, 
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was  initially  effective  at  a  concentration of 1 pg 
per  ml  of  medium,  it  did  not  support  growth 
indefinitely.  Such  would  be  the  expected  result 
eithec  if  the  substwnce  they  isolated  were  not 
identical  with  the  alpha-one  protein  or  if  the 
defined  base  medium  were  inadequate  (14). 
Their  report  lacks  any  data  on  starch  or  acryla- 
mide gel electrophoresis by which to compare the 
identity and  purity of the two substances. 
None of the small molecular weight compounds 
used  by  Ham  (11)  or  Michl  (23)  initiated  the 
immediate  growth  of unadapted  ceils,  and  thus 
did  not  duplicate  the  effects  produced  by  the 
alpha-one  protein.  Michl  (23)  has  degraded  his 
calf serum fractions,  producing  a  smaller molecu- 
lar weight substance  with cell flattening ability in 
which  10  different  amino  acids  were  identified. 
As  of  now,  the  alpha-one  protein  derived  from 
human  serum  has  not been  successfully degraded 
without  losing  the  biological  activity  defined  in 
this report. 
The rate of growth of "unadapted"  conjunctiva 
cells in the presence of the alpha  protein,  as com- 
pared  to  their  rate  of growth  in  the  chemically 
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